GS Investments’s Celgene Corp CELG Stock Holding History

GS Investments’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,060	Closed	-$2.09M	–	130
2019 Q3	$2.09M	Hold	21,060	–	–	1.53%	27
2019 Q2	$1.95M	Hold	21,060	–	–	1.59%	25
2019 Q1	$1.99M	Hold	21,060	–	–	1.56%	28
2018 Q4	$1.35M	Sell	21,060 -2,045	-9%	-$151K	1.13%	35
2018 Q3	$2.07M	Sell	23,105 -70	-0.3%	-$6.19K	1.45%	30
2018 Q2	$1.84M	Sell	23,175 -358	-2%	-$29.7K	1.37%	29
2018 Q1	$2.1M	Buy	23,533 +180	+0.8%	+$17.3K	1.54%	26
2017 Q4	$2.44M	Buy	23,353 +4,153	+22%	+$469K	1.86%	20
2017 Q3	$2.8M	Buy	19,200 +35	+0.2%	+$4.77K	2.24%	12
2017 Q2	$21.5M	Buy	+19,165	New	+$2.35M	16.1%	1

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

GS Investments's CELG Position: Q4 2019 in Review

GS Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 21,060 shares — an estimated $2.09M sold.

GS Investments first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $21.5M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

GS Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
GS Investments sold 21,060 Celgene Corp shares in Q4 2019, an estimated $2.09M.
GS Investments first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
GS Investments's Celgene Corp position peaked at $21.5M in Q2 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on GS Investments's 13F filing for Q4 2019, filed 4 Feb 2020.